Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Vidal, Adriana C ^a   Lund, Pauline K ^b   Hoyo, Cathrine ^a   Galanko, Joseph ^b   Burcal, Lauren ^b   Holston, Rachel ^b   Massa, Berri ^b   Omofoye, Oluwaseun ^b   Sandler, Robert S ^b   Keku, Temitope O ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

C peptide; Insulin; Insulin like growth factor binding protein

Indexed keywords

C PEPTIDE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; BODY MASS; CANCER RISK; CARCINOGENESIS; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FAMILY HISTORY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OBESITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME; UPREGULATION; WAIST HIP RATIO;

ADENOMA; ADULT; AGED; APOPTOSIS; BODY MASS INDEX; C-PEPTIDE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INTESTINAL MUCOSA; MALE; MIDDLE AGED; ODDS RATIO; RISK;

EID: 84865659463     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-389     Document Type: Article

References (41)

1. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998, 339:1277-1284. 10.1056/NEJM199810293391803, 9791143.
2. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
3. Sridhar SS. Insulin-Insulin-like growth factor axis and colon cancer. J Clin Oncol 2009, 27:165-167. 10.1200/JCO.2008.19.8937, 19064959.
4. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996, 5:1013-1015.
5. Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Eyssen G, Bruce WR, Giacca A. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 2006, 147:1830-1837.
6. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001, 131(11 Suppl):3109S-3120S.
7. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 1989, 80:51-58. 10.1111/j.1349-7006.1989.tb02244.x, 2540132.
8. Braulke T, Tippmer S, Neher E, von Figura K. Regulation of the mannose 6- phosphate/IGF II receptor expression at the cell surface by mannose 6-phosphate, insulin like growth factors and epidermal growth factor. EMBO J 1989, 8:681-686. 400861, 2542023.
9. Le Roith D, Parrizas M, Blakesley VA. The insulin-like growth factor-I receptor and apoptosis. Implications for the aging progress. Endocrine 1997, 7:103-105.
10. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 2002, 277:39684-39695. 10.1074/jbc.M202766200, 12138094.
11. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 2009, 30:586-623. 10.1210/er.2008-0047, 19752219.
12. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001, 60:91-106. 10.1079/PNS200070, 11310428.
13. Scharf J, Ramadori G, Braulke T, Hartmann H. Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulinlike growth factor, and growth hormone. Hepatology 1996, 23:818-827. 10.1002/hep.510230424, 8666337.
14. Katz LE, Jawad AF, Ganesh J, Abraham M, Murphy K, Lipman TH. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis. Pediatr Diabetes 2007, 8:53-59. 10.1111/j.1399-5448.2007.00236.x, 17448127.
15. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988, 66:266-272. 10.1210/jcem-66-2-266, 2448329.
16. Sato Y, Chen Z, Miyazaki K. Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25. Cancer Sci 2007, 98:1055-1063. 10.1111/j.1349-7006.2007.00502.x, 17465992.
17. Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005, 14:2076-2081. 10.1158/1055-9965.EPI-05-0239, 16172212.
18. Keku TO, Sandler RS, Simmons JG, Galanko J, Woosley JT, Proffitt M, Omofoye O, McDoom M, Lund PK. Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas. BMC Cancer 2008, 8:143. 10.1186/1471-2407-8-143, 2409350, 18498652.
19. Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, Nieters A, Biessy C, Tjonneland A, Olsen A, Overvad K, Gronbaek H, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Boeing H, Pischon T, Trichopoulos D, Oikonomou E, Trichopoulou A, Panico S, Vineis P, Berrino F, Tumino R, Masala G, Peters PH, van Gils CH, Bueno-de-Mesquita HB, Ocke MC, Lund E, Mendez MA, Tormo MJ, Barricarte A, Martinez-Garcia C, Dorronsoro M, Quiros JR, Hallmans G, Palmqvist R, Berglund G, Manjer J, Key T, Allen NE, Bingham S, Khaw KT, Cust A, Kaaks R. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007, 121:368-376. 10.1002/ijc.22697, 17372899.
20. Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005, 129:464-475.
21. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E. C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 2006, 15:750-755. 10.1158/1055-9965.EPI-05-0820, 16614119.
22. Le Marchand L, Wang H, Rinaldi S, Kaaks R, Vogt TM, Yokochi L, Decker R. Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population. Cancer Epidemiol Biomarkers Prev 2010, 19:1471-1477. 10.1158/1055-9965.EPI-10-0128, 2882992, 20501760.
23. Tsilidis KK, Brancati FL, Pollak MN, Rifai N, Clipp SL, Hoffman-Bolton J, Helzlsouer KJ, Platz EA. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 2010, 21:1-10. 10.1007/s10552-009-9428-6, 3010872, 19774471.
24. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia. Int J Obesity (London) 2012, 36:440-447.
25. Ransohoff DF, Martin C, Wiggins WS, Hitt BA, Keku TO, Galanko JA, Sandler RS. Assessment of serum proteomics to detect large colon adenomas. Cancer Epidemiol Biomarkers Prev 2008, 17:2188-2193. 10.1158/1055-9965.EPI-07-2767, 2561171, 18708413.
26. Vinikoor LC, Schroeder JC, Millikan RC, Satia JA, Martin CF, Ibrahim J, Galanko JA, Sandler RS. Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol 2008, 168:289-297. 10.1093/aje/kwn134, 2533637,2533637, 18587137.
27. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001, 154:1089-1099. 10.1093/aje/154.12.1089, 11744511.
28. Hovorka R, Jones RH. How to measure insulin secretion. Diabetes Metab Rev 1994, 10:91-117. 10.1002/dmr.5610100204, 7956679.
29. Keku T, Vidal A, Oliver S, Hoyo C, Hall IJ, Omofoye S, McDoom M, Worly K, Galanko J, Sandler RS, Millikan R. Genetics variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African American and Whites. Cancer Causes Control 2012, 23:1127-1138. 10.1007/s10552-012-9981-2, 22565227.
30. Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden. Int J Cancer 2003, 107:89-93. 10.1002/ijc.11362, 12925961.
31. Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004, 96:546-553. 10.1093/jnci/djh082, 15069117.
32. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000, 92:1592-1600. 10.1093/jnci/92.19.1592, 11018095.
33. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005, 14:850-855. 10.1158/1055-9965.EPI-04-0661, 15824155.
34. Jacobs ET, Martinez ME, Alberts DS, Ashbeck EL, Gapstur SM, Lance P, Thompson PA. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis. Cancer Epidemiol Biomarkers Prev 2008, 17:300-305. 10.1158/1055-9965.EPI-07-0764, 18250342.
35. Collett-Solberg PF, Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 2000, 12:121-136. 10.1385/ENDO:12:2:121, 10905372.
36. Murphy LJ, Rajkumar K, Molnar P. Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice. Prog Growth Factor Res 1995, 6:425-432. 10.1016/0955-2235(95)00026-7, 8817686.
37. LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2007, 3:302-310.
38. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007, 86:s836-s842.
39. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, Halkjaer J, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Guernec G, Bergmann MM, Linseisen J, Becker N, Trichopoulou A, Trichopoulos D, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, Bueno-de-Mesquita HB, Boshuizen HC, Van Guelpen B, Palmqvist R, Berglund G, Gonzalez CA, Dorronsoro M, Barricarte A, Navarro C, Martinez C, Quiros JR, Roddam A, Allen N, Bingham S, Khaw KT, Ferrari P, Kaaks R, Slimani N, Riboli E. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006, 98:920-931. 10.1093/jnci/djj246, 16818856.
40. Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Zinman B. Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentration. J Clin Endocrinol Metab 2002, 87:77-83. 10.1210/jc.87.1.77, 11788626.
41. Okosun IS, Chandra KM, Boev A, Boltri JM, Choi ST, Parish DC, Dever GE. Abdominal adiposity in U.S. adults: prevalence and trends, 1960-2000. Prev Med 2004, 39:197-206. 10.1016/j.ypmed.2004.01.023, 15208003.